Ain Shams University faculty of medicine
Cairo, Egypt
Location contact
Ain Shams University faculty of medicine Ain Shams Universit faculty of medicine
CONTACT
NCT Number: NCT06935669
The objective of this study is to compare the efficacy of transversalis fascia plane block using bupivacaine and ketamine versus bupivacaine alone for pain management after cesarean section under spinal anaesthesia.
Trial opening soon.
Get Notified21 year–45 year
Female
Interventional
Phase 1
Cairo, Egypt
Ain Shams University faculty of medicine Ain Shams Universit faculty of medicine
CONTACT
Cesarean section (CS) is one of the most common surgeries and usually causes moderate to severe pain for up to 48 h. The rate of CS, which is a life-saving surgical procedure in cases of certain complications that occur during pregnancy and birth, has exceeded 20% worldwide Pain control after CS has crucial importance, especially in the first 24 h, to facilitate early ambulation and the establishment of breastfeeding. Insufficient analgesia in the postoperative period may cause a number of undesirable effects, such as patient discomfort, thromboembolism due to extended immobilization, and increased pulmonary secretions resulting in complications The well-known side effects of analgesic morphine as nausea, vomiting, itching and sedation, may interfere with the interaction between mother and child, breastfeeding and post-partum experience in a dose-dependent manner. However, a number of alternative strategies have been described in order to reduce morphine consumption post-operatively .
The mode and type of analgesia should be safe and effective. A stimulus caused by a lesion in tissue or organs during surgery is the cause of postoperative pain .
The primary source of pain after abdominal surgeries, including CS, are the anterior abdominal wall and abdominal viscera, and blocking these areas could provide proper postoperative analgesia .
Recently, the application of fascial plane blocks has increased due to the widespread use of ultrasound among anesthesiologists and the avoidance of opioids in a multimodal analgesic strategy. Different regional anesthetic techniques have been introduced, including ilioinguinal nerve blocks, abdominal field blocks, Transversalis Fascia Plane (TFP) blocks, and Transversus Abdominis Plane (TAP) blocks to alleviate pain from the abdominal wall incision .
Transversalis Fascia Plane, performed in the posterior axillary line, blocks branches of L1 nerve roots, including ilioinguinal and iliohypogastric nerves. This method has been used to control postoperative pain in patients undergoing different lower abdominal surgeries A variety of anesthetic agents such as bupivacaine, levobupivacaine, and ropivacaine are commonly used in TAP blocks. These drugs provide short-term analgesia and primarily alleviate somatic pain. To extend the duration of analgesic efficacy, various adjuvants such as opioids, ketamine, clonidine, and alpha-2 agonists like dexmedetomidine have been added .
Bupivacaine is one of the widely used local analgesics. ketamine affects pain modulation through multiple mechanisms of action. It is a non-competitive N-methyl-d-aspartate (NMDA) receptor antagonist, which exerts an anti-hyperalgesic effect by decreasing central sensitization and reducing the wind-up phenomenon in the postoperative period .
The aim of this study is to investigate the effect of transversalis fascia plane block using bupivacaine plus ketamine on postoperative pain compared to bupivacaine alone in patients undergoing cesarean section under spinal anaesthesia.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients in this group will receive a transversalis fascia plane block using a combination of bupivacaine and ketamine.
Other names: Ketalar
Control group to evaluate the additional effect of ketamine in the experimental arm.
Other names: Marcaine
Patients in this group will receive a transversalis fascia plane block using a combination of bupivacaine and ketamine.
Other names: Marcaine
Time frame: day 1
Pain intensity will be assessed using the Visual Analog Scale (VAS), where 0 = no pain and 10 = worst pain.
Patients will report their pain levels at rest and during movement at 24 hours after the transversalis fascia plane block.
The mean VAS score will be compared between the ketamine + bupivacaine group and the bupivacaine-only group.
Time frame: Day 1
Time (in minutes/hours) from the completion of the transversalis fascia plane block to the administration of the first dose of rescue analgesia will be recorded.
Rescue analgesia will be given when the patient reports a VAS score ≥ 4 or requests additional pain relief.
A longer time to first rescue analgesia in the ketamine + bupivacaine group would indicate prolonged analgesic duration compared to the bupivacaine-only group.
Time frame: Day 1
Rescue analgesia will be given when the patient reports a VAS score ≥ 4 or requests additional pain relief.
Contact information is provided by the study sponsor or research team.
Ahmed Ad MAHMOUD Ebrahim elgamal
CONTACT
Eman Sh Abdelmaqsoud
CONTACT
Ain Shams University
Other
Randomised Controlled Clinical Trial Analgesic Effect of Bupivacaine Plus Ketamine Versus Bupivacaine Alone in Transversalis Fascia Plane Block After Cesarean Section Under Spinal Anaesthesia
Acronym: TFBP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07736989
Agnosia, Analgesia
View Trial DetailsNCT07719868
Agnosia, Analgesia
View Trial DetailsNCT07700784
Agnosia, Analgesia
View Trial DetailsNCT07692659
Agnosia, Analgesia
View Trial Details